In vitro differentiation of human pluripotent stem cells into the B lineage using OP9-MS5 co-culture
Summary
In vitro differentiation of human pluripotent stem cells (hPSCs) offers a genetically tractable system to examine the physiology and pathology of human tissue development and differentiation. We have used this approach to model the earliest stages of human B lineage development and characterize potential target cells for the in utero initiation of childhood B acute lymphoblastic leukemia. Herein, we detail critical aspects of the protocol including reagent validation, controls, and examples of surface markers used for analysis and cell sorting. For complete details on the use and execution of this protocol, please refer to Boiers et al. (2018). © 2021 The Author(s).
| Authors | Richardson SE, Ghazanfari R, Chhetri J, Enver T, Böiers C |
|---|---|
| Journal | STAR protocols |
| Publication Date | 2021 Jun 18;2(2):100420 |
| PubMed | 33899010 |
| PubMed Central | PMC8053808 |
| DOI | 10.1016/j.xpro.2021.100420 |